Eisai Co., Ltd.
$33.30
24H
Market Cap
Volume
Supply
Price Chart
About Eisai Co., Ltd. - 4523.T
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, known for its research, development, manufacture, and sales of pharmaceuticals, including treatments for Alzheimer's disease, epilepsy, and cancer.
What are Eisai Co., Ltd.'s core values and mission statement?
Eisai Co., Ltd. is dedicated to improving global health through innovative pharmaceutical solutions, guided by their human health care (hhc) philosophy, which places the well-being of patients and their families at the center of their operations. Their mission includes a commitment to providing first-rate programs and services, and their core values emphasize compassion, integrity, and the relentless pursuit of scientific excellence.
Who founded Eisai Co., Ltd. and when?
Eisai Co., Ltd. was founded by Toyoji Naito in 1941.
Who leads Eisai Co., Ltd.?
As of the last update, Eisai Co., Ltd. is led by Haruo Naito, who serves as the CEO.
Where is Eisai Co., Ltd. located, and what is its base country?
Eisai Co., Ltd. is headquartered in Tokyo, Japan, which is also its base country.
On which exchanges is Eisai Co., Ltd. traded?
Eisai Co., Ltd. is traded on the Tokyo Stock Exchange under the ticker symbol 4523 and it is also listed on the OTC Markets Group in the United States under the ticker symbol ESALY.
Historical data
Eisai Co., Ltd. (4523) Price Live Data
The live price of Eisai Co., Ltd. (4523) is $33.30, with a trading volume of 1,725,400 in the last 24 hours. Wrapstocks updates the 4523 price in real-time. Eisai Co., Ltd. is down -1.34% in the last 24 hours. The company has a live market cap of $9,393,234,149.38 and a supply of 282,051,999 4523 stocks.
Eisai Co., Ltd. (4523) is traded on Tokyo Stock Exchange, and currently, the market is closed; trading will be resumed in 11 hours and 0 minutes.
